Nuclear installations
東亜ST・STファーム、第3四半期そろって増収増益
東亜製薬グループの中核子会社である東亜STとエスティファームは、今年第3四半期の売上高と営業利益がいずれも前年同期を上回った。新薬開発子会社の東亜STは27日、今年第3四半期の単体ベースの営業利益が前年同期比27.7％増の214億ウォンだったと発表した。同期間の売上高は4.1％増の2065億ウォンで、2四半期連続で四半期売上高が2000億ウォンを超えた
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More on Nuclear installations
- How China Is Setting the Pace on Nuclear PowerSama Bilbao y Leon, Director General of the World Nuclear Association, says China’s 59 reactors under construction demonstrate a programmatic approach to nuclear development that Western Europe and...
- Irán cuestiona la imparcialidad del OIEA antes de que la ONU examine su programa nuclear
- In a pickle in JamnagarTHE massive Reliance refinery in Jamnagar abutting the Arabian Sea from its perch in Gujarat was inaugurated in December 1999. There may be absolutely no connection between the refinery’s birthday...
- Nuclear watchdog set to decide on 10-yr lifespan extension for Kori units 3, 4SEOUL, Oct. 27 (Yonhap) -- The country's nuclear watchdog was set to decide Tues...
- What if Dems didn't scuttle Henry Wallace VP nomination in 1945?Angelenos are in for a treat. Some little-known but extraordinarily-consequential history is being presented in an absolutely riveting 50-actor immersive play aptly titled “Convention,” which opene...
- International Ministerial Conference on Nuclear Power kicks off in S. KoreaINCHEON, Oct. 27 (Yonhap) -- A quadrennial, high-level policy event organized by...